Goss CH - Search Results

1

Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation.

Sanders DB, Khan U, Heltshe SL, Skalland M, West NE, VanDevanter DR, Goss CH, Flume PA; STOP2 Investigators. Sanders DB, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jul;21(4):574-580. doi: 10.1016/j.jcf.2021.11.009. Epub 2021 Nov 29. J Cyst Fibros. 2022. PMID: 34857494 Free PMC article. Clinical Trial.

2

Aggressive prenatal care results in successful fetal outcomes in CF women.

Cheng EY, Goss CH, McKone EF, Galic V, Debley CK, Tonelli MR, Aitken ML. Cheng EY, et al. Among authors: goss ch. J Cyst Fibros. 2006 May;5(2):85-91. doi: 10.1016/j.jcf.2006.01.002. J Cyst Fibros. 2006. PMID: 16650742 Free article.

3

Laboratory parameter profiles among patients with cystic fibrosis.

Goss CH, Mayer-Hamblett N, Kronmal RA, Williams J, Ramsey BW. Goss CH, et al. J Cyst Fibros. 2007 Apr;6(2):117-23. doi: 10.1016/j.jcf.2006.05.012. Epub 2006 Jul 7. J Cyst Fibros. 2007. PMID: 16829217 Free article.

This data was presented in poster format at the American Thoracic Society International Conference, Atlanta, USA, 2002, appearing subsequently in the Conference proceedings [Goss CH, Mayer-Hamblett N, Yunker A, Waltz DA, Kronmal RA, Ramsey BW. ...

This data was presented in poster format at the American Thoracic Society International Conference, Atlanta, USA, 2002, appearing subsequent …

4

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis.

Goss CH, McKone EF, Mathews D, Kerr D, Wanger JS, Millard SP; Cystic Fibrosis Therapeutics Development Network. Goss CH, et al. J Cyst Fibros. 2008 Mar;7(2):147-53. doi: 10.1016/j.jcf.2007.07.006. Epub 2007 Aug 28. J Cyst Fibros. 2008. PMID: 17728193 Free article. Clinical Trial.

5

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B; Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Flume PA, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69. doi: 10.1164/rccm.200705-664OC. Epub 2007 Aug 29. Am J Respir Crit Care Med. 2007. PMID: 17761616

6

Contraceptive practices in women with cystic fibrosis.

Plant BJ, Goss CH, Tonelli MR, McDonald G, Black RA, Aitken ML. Plant BJ, et al. Among authors: goss ch. J Cyst Fibros. 2008 Sep;7(5):412-4. doi: 10.1016/j.jcf.2008.03.001. Epub 2008 Apr 1. J Cyst Fibros. 2008. PMID: 18387346 Free article.

7

Patient-reported respiratory symptoms in cystic fibrosis.

Goss CH, Edwards TC, Ramsey BW, Aitken ML, Patrick DL. Goss CH, et al. J Cyst Fibros. 2009 Jul;8(4):245-52. doi: 10.1016/j.jcf.2009.04.003. Epub 2009 May 29. J Cyst Fibros. 2009. PMID: 19481983 Free article.

8

Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee. Flume PA, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3. Am J Respir Crit Care Med. 2009. PMID: 19729669 Review.

9

Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis.

Sanders DB, Hoffman LR, Emerson J, Gibson RL, Rosenfeld M, Redding GJ, Goss CH. Sanders DB, et al. Among authors: goss ch. Pediatr Pulmonol. 2010 Feb;45(2):127-34. doi: 10.1002/ppul.21117. Pediatr Pulmonol. 2010. PMID: 20054859

10

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Sanders DB, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2010 Sep 1;182(5):627-32. doi: 10.1164/rccm.200909-1421OC. Epub 2010 May 12. Am J Respir Crit Care Med. 2010. PMID: 20463179 Free PMC article.

11

Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee. Flume PA, et al. Am J Respir Crit Care Med. 2010 Aug 1;182(3):298-306. doi: 10.1164/rccm.201002-0157OC. Am J Respir Crit Care Med. 2010. PMID: 20675678

12

Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis.

Bennett AV, Patrick DL, Lymp JF, Edwards TC, Goss CH. Bennett AV, et al. Among authors: goss ch. J Cyst Fibros. 2010 Dec;9(6):419-24. doi: 10.1016/j.jcf.2010.08.008. J Cyst Fibros. 2010. PMID: 20817624 Free article.

13

Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.

Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Sanders DB, et al. Among authors: goss ch. Pediatr Pulmonol. 2011 Apr;46(4):393-400. doi: 10.1002/ppul.21374. Epub 2010 Oct 21. Pediatr Pulmonol. 2011. PMID: 20967845

14

Review: Staphylococcus aureus and MRSA in cystic fibrosis.

Goss CH, Muhlebach MS. Goss CH, et al. J Cyst Fibros. 2011 Sep;10(5):298-306. doi: 10.1016/j.jcf.2011.06.002. Epub 2011 Jun 29. J Cyst Fibros. 2011. PMID: 21719362 Free article. Review.

15

Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state.

Quon BS, Patrick DL, Edwards TC, Aitken ML, Gibson RL, Genatossio A, McNamara S, Goss CH. Quon BS, et al. Among authors: goss ch. J Cyst Fibros. 2012 May;11(3):216-22. doi: 10.1016/j.jcf.2011.12.002. Epub 2012 Jan 4. J Cyst Fibros. 2012. PMID: 22226414 Free PMC article.

16

Aztreonam for inhalation solution, challenges to drug approval and integration into CF care.

Goss CH, Bell SC. Goss CH, et al. J Cyst Fibros. 2013 Mar;12(2):99-101. doi: 10.1016/j.jcf.2012.08.006. Epub 2012 Sep 19. J Cyst Fibros. 2013. PMID: 22999443 Free article. No abstract available.

17

Pulmonary exacerbations as indicators of progression of lung disease in young children with CF.

Sanders DB, Goss CH. Sanders DB, et al. Among authors: goss ch. Thorax. 2013 Jul;68(7):608-9. doi: 10.1136/thoraxjnl-2013-203262. Epub 2013 Mar 29. Thorax. 2013. PMID: 23542463 No abstract available.

18

Pulmonary exacerbations in CF patients with early lung disease.

Anstead M, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Goss CH, Rose L, Burns JL, Marshall B, Ratjen F. Anstead M, et al. Among authors: goss ch. J Cyst Fibros. 2014 Jan;13(1):74-9. doi: 10.1016/j.jcf.2013.07.006. Epub 2013 Sep 10. J Cyst Fibros. 2014. PMID: 24029220 Free article. Clinical Trial.

19

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Lechtzin N, West N, Allgood S, Wilhelm E, Khan U, Mayer-Hamblett N, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Goss CH. Lechtzin N, et al. Among authors: goss ch. Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19. Contemp Clin Trials. 2013. PMID: 24055998 Free PMC article. Clinical Trial.

20

European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis.

Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C. Stern M, et al. Among authors: goss ch. J Cyst Fibros. 2014 May;13 Suppl 1:S43-59. doi: 10.1016/j.jcf.2014.03.011. J Cyst Fibros. 2014. PMID: 24856777 Free article. Review.

21

Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.

Conrad C, Lymp J, Thompson V, Dunn C, Davies Z, Chatfield B, Nichols D, Clancy J, Vender R, Egan ME, Quittell L, Michelson P, Antony V, Spahr J, Rubenstein RC, Moss RB, Herzenberg LA, Goss CH, Tirouvanziam R. Conrad C, et al. Among authors: goss ch. J Cyst Fibros. 2015 Mar;14(2):219-27. doi: 10.1016/j.jcf.2014.08.008. Epub 2014 Sep 13. J Cyst Fibros. 2015. PMID: 25228446 Free article. Clinical Trial.

22

Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.

McKone EF, Velentgas P, Swenson AJ, Goss CH. McKone EF, et al. Among authors: goss ch. J Cyst Fibros. 2015 Sep;14(5):580-6. doi: 10.1016/j.jcf.2015.01.005. Epub 2015 Feb 3. J Cyst Fibros. 2015. PMID: 25660278 Free article.

23

Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.

Heltshe SL, Goss CH, Thompson V, Sagel SD, Sanders DB, Marshall BC, Flume PA. Heltshe SL, et al. Among authors: goss ch. Thorax. 2016 Mar;71(3):223-9. doi: 10.1136/thoraxjnl-2014-206750. Epub 2015 Apr 24. Thorax. 2016. PMID: 25911223 Free PMC article.

24

Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States.

Ramos KJ, Quon BS, Psoter KJ, Lease ED, Mayer-Hamblett N, Aitken ML, Goss CH. Ramos KJ, et al. Among authors: goss ch. J Cyst Fibros. 2016 Mar;15(2):196-203. doi: 10.1016/j.jcf.2015.11.005. Epub 2015 Dec 17. J Cyst Fibros. 2016. PMID: 26704622 Free PMC article.

25

Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.

Heltshe SL, Goss CH. Heltshe SL, et al. Among authors: goss ch. Thorax. 2016 Feb;71(2):101-2. doi: 10.1136/thoraxjnl-2015-208057. Thorax. 2016. PMID: 26769012 Free PMC article. No abstract available.

26

CFTR modulators and pregnancy: Our work has only just begun.

Goss CH, VanDevanter DR. Goss CH, et al. J Cyst Fibros. 2016 Jan;15(1):6-7. doi: 10.1016/j.jcf.2015.12.019. Epub 2016 Jan 7. J Cyst Fibros. 2016. PMID: 26774758 Free article. No abstract available.

27

Cystic Fibrosis: The Dawn of a New Therapeutic Era.

Heltshe SL, Cogen J, Ramos KJ, Goss CH. Heltshe SL, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2017 Apr 15;195(8):979-984. doi: 10.1164/rccm.201606-1250PP. Am J Respir Crit Care Med. 2017. PMID: 27710011 Free PMC article. No abstract available.

28

Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV₁ < 30% of Predicted in the United States.

Ramos KJ, Quon BS, Heltshe SL, Mayer-Hamblett N, Lease ED, Aitken ML, Weiss NS, Goss CH. Ramos KJ, et al. Among authors: goss ch. Chest. 2017 Jun;151(6):1320-1328. doi: 10.1016/j.chest.2017.01.019. Epub 2017 Jan 20. Chest. 2017. PMID: 28115168 Free PMC article.

29

Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.

Somayaji R, Goss CH, Khan U, Neradilek M, Neuzil KM, Ortiz JR. Somayaji R, et al. Among authors: goss ch. Clin Infect Dis. 2017 Jun 15;64(12):1760-1767. doi: 10.1093/cid/cix203. Clin Infect Dis. 2017. PMID: 28329304 Free PMC article.

30

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.

VanDevanter DR, Heltshe SL, Spahr J, Beckett VV, Daines CL, Dasenbrook EC, Gibson RL, Raksha J, Sanders DB, Goss CH, Flume PA; STOP Study Group. VanDevanter DR, et al. Among authors: goss ch. J Cyst Fibros. 2017 Sep;16(5):607-615. doi: 10.1016/j.jcf.2017.04.004. Epub 2017 Apr 21. J Cyst Fibros. 2017. PMID: 28438499 Free PMC article.

31

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.

West NE, Beckett VV, Jain R, Sanders DB, Nick JA, Heltshe SL, Dasenbrook EC, VanDevanter DR, Solomon GM, Goss CH, Flume PA; STOP investigators. West NE, et al. Among authors: goss ch. J Cyst Fibros. 2017 Sep;16(5):600-606. doi: 10.1016/j.jcf.2017.04.003. Epub 2017 Apr 29. J Cyst Fibros. 2017. PMID: 28457954 Free PMC article.

32

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.

Sanders DB, Solomon GM, Beckett VV, West NE, Daines CL, Heltshe SL, VanDevanter DR, Spahr JE, Gibson RL, Nick JA, Marshall BC, Flume PA, Goss CH; STOP Study Group. Sanders DB, et al. Among authors: goss ch. J Cyst Fibros. 2017 Sep;16(5):592-599. doi: 10.1016/j.jcf.2017.04.005. Epub 2017 Apr 29. J Cyst Fibros. 2017. PMID: 28460885 Free PMC article.

33

Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.

Lechtzin N, Mayer-Hamblett N, West NE, Allgood S, Wilhelm E, Khan U, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Gibson RL, Orenstein D, Milla C, Clancy JP, Antony V, Goss CH; eICE Study Team. Lechtzin N, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1144-1151. doi: 10.1164/rccm.201610-2172OC. Am J Respir Crit Care Med. 2017. PMID: 28608719 Free PMC article. Clinical Trial.

34

Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation.

Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML. Kapnadak SG, et al. Among authors: goss ch. J Cyst Fibros. 2017 Nov;16(6):735-743. doi: 10.1016/j.jcf.2017.07.015. Epub 2017 Jul 28. J Cyst Fibros. 2017. PMID: 28757079 Free PMC article.

35

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, Konstan MW, Morgan WJ, Pasta DJ, Moss RB. Wagener JS, et al. Among authors: goss ch. J Cyst Fibros. 2018 Jul;17(4):503-510. doi: 10.1016/j.jcf.2017.10.003. Epub 2017 Oct 31. J Cyst Fibros. 2018. PMID: 29100868 Free PMC article.

36

Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.

Heltshe SL, West NE, VanDevanter DR, Sanders DB, Beckett VV, Flume PA, Goss CH; STOP Study Group. Heltshe SL, et al. Among authors: goss ch. Contemp Clin Trials. 2018 Jan;64:35-40. doi: 10.1016/j.cct.2017.11.012. Epub 2017 Nov 21. Contemp Clin Trials. 2018. PMID: 29170074 Free PMC article. Clinical Trial.

37

Epidemiology of CF: How registries can be used to advance our understanding of the CF population.

Jackson AD, Goss CH. Jackson AD, et al. Among authors: goss ch. J Cyst Fibros. 2018 May;17(3):297-305. doi: 10.1016/j.jcf.2017.11.013. Epub 2017 Dec 21. J Cyst Fibros. 2018. PMID: 29275954 Free article. Review.

38

Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0-11years.

Edwards TC, Emerson J, Genatossio A, McNamara S, Goss C, Patrick DL, Onchiri F, Rosenfeld M. Edwards TC, et al. J Cyst Fibros. 2018 Sep;17(5):680-686. doi: 10.1016/j.jcf.2017.12.008. Epub 2018 Feb 1. J Cyst Fibros. 2018. PMID: 29358075 Free PMC article.

39

The Long and the Short of It in Cystic Fibrosis Clinical Research Outcomes.

West NE, Goss CH, Nichols DP. West NE, et al. Among authors: goss ch. Ann Am Thorac Soc. 2018 Apr;15(4):430-431. doi: 10.1513/AnnalsATS.201801-056ED. Ann Am Thorac Soc. 2018. PMID: 29600892 Free PMC article. No abstract available.

40

Reply to Martelli et al.: eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed.

Lechtzin N, Mayer-Hamblett N, Khan U, Goss CH. Lechtzin N, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2018 Jul 15;198(2):285-286. doi: 10.1164/rccm.201803-0481LE. Am J Respir Crit Care Med. 2018. PMID: 29698612 Free PMC article. No abstract available.

41

Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.

Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW; OPTIMIZE Study Group. Mayer-Hamblett N, et al. Am J Respir Crit Care Med. 2018 Nov 1;198(9):1177-1187. doi: 10.1164/rccm.201802-0215OC. Am J Respir Crit Care Med. 2018. PMID: 29890086 Free PMC article. Clinical Trial.

42

Benefits of set length antibiotic treatment for pulmonary exacerbations.

Goss CH, Somayaji R, Flume PA. Goss CH, et al. Lancet Respir Med. 2018 Aug;6(8):575-577. doi: 10.1016/S2213-2600(18)30267-4. Epub 2018 Jun 27. Lancet Respir Med. 2018. PMID: 29960882 Free PMC article. No abstract available.

43

Correspondence between symptoms and preference-based health status measures in the STOP study.

Gold LS, Patrick DL, Hansen RN, Beckett V, Goss CH, Kessler L. Gold LS, et al. Among authors: goss ch. J Cyst Fibros. 2019 Mar;18(2):251-264. doi: 10.1016/j.jcf.2018.08.001. Epub 2018 Aug 29. J Cyst Fibros. 2019. PMID: 30170756 Free PMC article.

44

CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Gifford AH, Heltshe SL, Goss CH. Gifford AH, et al. Among authors: goss ch. Ann Am Thorac Soc. 2019 Mar;16(3):331-340. doi: 10.1513/AnnalsATS.201807-449OC. Ann Am Thorac Soc. 2019. PMID: 30580531 Free PMC article.

45

Addressing lung transplant with adults with cystic fibrosis: A qualitative analysis of patients' perspectives and experiences.

Ramos KJ, Hobler MR, Engelberg RA, Curtis JR, Zander MI, Howard SS, Goss CH, Aitken ML. Ramos KJ, et al. Among authors: goss ch. J Cyst Fibros. 2019 May;18(3):416-419. doi: 10.1016/j.jcf.2019.04.007. Epub 2019 Apr 17. J Cyst Fibros. 2019. PMID: 31003953 Free PMC article.

46

Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS).

Gold LS, Patrick DL, Hansen RN, Goss CH, Kessler L. Gold LS, et al. Among authors: goss ch. J Cyst Fibros. 2019 Nov;18(6):886-893. doi: 10.1016/j.jcf.2019.05.009. Epub 2019 May 22. J Cyst Fibros. 2019. PMID: 31126901 Free PMC article.

47

Acute Pulmonary Exacerbations in Cystic Fibrosis.

Goss CH. Goss CH. Semin Respir Crit Care Med. 2019 Dec;40(6):792-803. doi: 10.1055/s-0039-1697975. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659730 Free PMC article. Review.

48

Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.

Nichols DP, Odem-Davis K, Cogen JD, Goss CH, Ren CL, Skalland M, Somayaji R, Heltshe SL. Nichols DP, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2020 Feb 15;201(4):430-437. doi: 10.1164/rccm.201906-1206OC. Am J Respir Crit Care Med. 2020. PMID: 31661302 Free PMC article.

49

Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function.

Kosamo S, Hisert KB, Dmyterko V, Nguyen C, Black RA, Holden TD, Radella F, Cotten PA, Goss CH, Aitken ML, Wurfel MM. Kosamo S, et al. Among authors: goss ch. J Cyst Fibros. 2020 Jul;19(4):608-613. doi: 10.1016/j.jcf.2019.11.009. Epub 2019 Dec 5. J Cyst Fibros. 2020. PMID: 31813753 Free PMC article.

50

Cystic Fibrosis: Advances in Understanding and Treatment.

Flume PA, Goss CH, VanDevanter D. Flume PA, et al. Among authors: goss ch. Semin Respir Crit Care Med. 2019 Dec;40(6):699-700. doi: 10.1055/s-0039-3400453. Epub 2019 Dec 30. Semin Respir Crit Care Med. 2019. PMID: 31887767 No abstract available.

51

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.

Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB; Global Registry Harmonization Group. Cosgriff R, et al. Among authors: goss ch. J Cyst Fibros. 2020 May;19(3):355-358. doi: 10.1016/j.jcf.2020.04.012. Epub 2020 Apr 25. J Cyst Fibros. 2020. PMID: 32376098 Free PMC article.

52

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Mayer-Hamblett N, van Koningsbruggen-Rietschel S, Nichols DP, VanDevanter DR, Davies JC, Lee T, Durmowicz AG, Ratjen F, Konstan MW, Pearson K, Bell SC, Clancy JP, Taylor-Cousar JL, De Boeck K, Donaldson SH, Downey DG, Flume PA, Drevinek P, Goss CH, Fajac I, Magaret AS, Quon BS, Singleton SM, VanDalfsen JM, Retsch-Bogart GZ. Mayer-Hamblett N, et al. Among authors: goss ch. J Cyst Fibros. 2020 Sep;19(5):677-687. doi: 10.1016/j.jcf.2020.05.011. Epub 2020 Jun 7. J Cyst Fibros. 2020. PMID: 32522463 Free PMC article. Review.

53

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment.

VanDevanter DR, Heltshe SL, Sanders DB, West NE, Skalland M, Flume PA, Goss CH; STOP-OB Study. VanDevanter DR, et al. Among authors: goss ch. J Cyst Fibros. 2021 Jan;20(1):36-38. doi: 10.1016/j.jcf.2020.08.006. Epub 2020 Aug 13. J Cyst Fibros. 2021. PMID: 32800708 Free PMC article.

54

Oral Glutathione and Growth in Cystic Fibrosis: A Multicenter, Randomized, Placebo-controlled, Double-blind Trial.

Bozic M, Goss CH, Tirouvanziam RM, Baines A, Kloster M, Antoine L, Borowitz D, Schwarzenberg SJ; GROW study group. Bozic M, et al. Among authors: goss ch. J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):771-777. doi: 10.1097/MPG.0000000000002948. J Pediatr Gastroenterol Nutr. 2020. PMID: 32960827 Free PMC article. Clinical Trial.

55

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.

McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. Among authors: goss ch. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.

56

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.

Bain R, Cosgriff R, Zampoli M, Elbert A, Burgel PR, Carr SB, Castaños C, Colombo C, Corvol H, Faro A, Goss CH, Gutierrez H, Jung A, Kashirskaya N, Marshall BC, Melo J, Mondejar-Lopez P, de Monestrol I, Naehrlich L, Padoan R, Pastor-Vivero MD, Rizvi S, Salvatore M, Filho LVRFDS, Brownlee KG, Haq IJ, Brodlie M. Bain R, et al. Among authors: goss ch. J Cyst Fibros. 2021 Jan;20(1):25-30. doi: 10.1016/j.jcf.2020.11.021. Epub 2020 Dec 3. J Cyst Fibros. 2021. PMID: 33309057 Free PMC article.

57

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.

Pearson K, Mayer-Hamblett N, Goss CH, Retsch-Bogart GZ, VanDalfsen JM, Burks P, Rosenbluth D, Clancy JP, Hoffman A, Nichols DP. Pearson K, et al. Among authors: goss ch. J Cyst Fibros. 2021 Mar;20(2):195-197. doi: 10.1016/j.jcf.2020.12.007. Epub 2020 Dec 15. J Cyst Fibros. 2021. PMID: 33349583 Free PMC article.

58

Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms.

Freeman AJ, Sathe M, Aliaj E, Borowitz D, Fogarty B, Goss CH, Freedman S, Heltshe SL, Khan U, Riva D, Roman C, Romasco M, Schwarzenberg SJ, Ufret-Vincenty CA, Moshiree B. Freeman AJ, et al. Among authors: goss ch. J Cyst Fibros. 2021 Jul;20(4):598-604. doi: 10.1016/j.jcf.2020.12.021. Epub 2021 Jan 13. J Cyst Fibros. 2021. PMID: 33451899 Free PMC article.

59

The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.

VanDevanter EJ, Heltshe SL, Skalland M, Lechtzin N, Nichols D, Goss CH. VanDevanter EJ, et al. Among authors: goss ch. J Cyst Fibros. 2021 Nov;20(6):932-936. doi: 10.1016/j.jcf.2021.02.012. Epub 2021 Mar 5. J Cyst Fibros. 2021. PMID: 33685776 Free PMC article. Clinical Trial.

60

Health care costs related to home spirometry in the eICE randomized trial.

Franz N, Rapp H, Hansen RN, Gold LS, Goss CH, Lechtzin N, Kessler LG. Franz N, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jan;21(1):61-69. doi: 10.1016/j.jcf.2021.02.014. Epub 2021 Mar 12. J Cyst Fibros. 2022. PMID: 33715993 Free PMC article. Clinical Trial.

61

Rates of adverse and serious adverse events in children with cystic fibrosis.

Pittman JE, Khan U, Laguna TA, Heltshe S, Goss CH, Sanders DB. Pittman JE, et al. Among authors: goss ch. J Cyst Fibros. 2021 Nov;20(6):972-977. doi: 10.1016/j.jcf.2021.02.013. Epub 2021 Mar 18. J Cyst Fibros. 2021. PMID: 33745860 Free PMC article.

62

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Gifford AH, Sanville JL, Sathe M, Heltshe SL, Goss CH. Gifford AH, et al. Among authors: goss ch. Pediatr Pulmonol. 2021 Jul;56(7):2048-2056. doi: 10.1002/ppul.25431. Epub 2021 Apr 26. Pediatr Pulmonol. 2021. PMID: 33860641 Free PMC article.

63

Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study.

Sathe M, Moshiree B, Vu PT, Khan U, Heltshe SL, Romasco M, Freedman SD, Schwarzenberg SJ, Goss CH, Freeman AJ. Sathe M, et al. Among authors: goss ch. J Cyst Fibros. 2021 Jul;20(4):605-611. doi: 10.1016/j.jcf.2021.07.002. Epub 2021 Jul 22. J Cyst Fibros. 2021. PMID: 34305007 Free PMC article.

64

Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population.

Ramos KJ, Wai TH, Sykes J, Ma X, Stephenson AL, Jennerich AL, Kapnadak SG, Mayer-Hamblett N, Goss CH. Ramos KJ, et al. Among authors: goss ch. J Cyst Fibros. 2022 May;21(3):471-474. doi: 10.1016/j.jcf.2021.08.008. Epub 2021 Aug 28. J Cyst Fibros. 2022. PMID: 34465539 Free PMC article.

65

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.

Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.

66

A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis.

Paynter A, Khan U, Heltshe SL, Goss CH, Lechtzin N, Hamblett NM. Paynter A, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jan;21(1):78-83. doi: 10.1016/j.jcf.2021.08.013. Epub 2021 Aug 31. J Cyst Fibros. 2022. PMID: 34474987 Free PMC article.

67

Low body mass index as a barrier to lung transplant in cystic fibrosis.

Jennerich AL, Pryor JB, Wai TYH, Kapnadak SG, Aitken ML, Goss CH, Ramos KJ. Jennerich AL, et al. Among authors: goss ch. J Cyst Fibros. 2022 May;21(3):475-481. doi: 10.1016/j.jcf.2021.12.001. Epub 2021 Dec 23. J Cyst Fibros. 2022. PMID: 34922852 Free PMC article.

68

C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.

VanDevanter DR, Heltshe SL, Skalland M, West NE, Sanders DB, Goss CH, Flume PA. VanDevanter DR, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jul;21(4):588-593. doi: 10.1016/j.jcf.2021.12.003. Epub 2021 Dec 18. J Cyst Fibros. 2022. PMID: 34933824 Free PMC article.

69

Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations.

Gold LS, Hansen RN, Patrick DL, Tabah A, Heltshe SL, Flume PA, Goss CH, West NE, Sanders DB, VanDevanter DR, Kessler L. Gold LS, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jul;21(4):594-599. doi: 10.1016/j.jcf.2022.03.001. Epub 2022 Mar 14. J Cyst Fibros. 2022. PMID: 35300932 Free PMC article. Clinical Trial.

70

Antipseudomonal treatment decisions during CF exacerbation management.

VanDevanter DR, West NE, Sanders DB, Skalland M, Goss CH, Flume PA, Heltshe SL. VanDevanter DR, et al. Among authors: goss ch. J Cyst Fibros. 2022 Sep;21(5):753-758. doi: 10.1016/j.jcf.2022.04.006. Epub 2022 Apr 22. J Cyst Fibros. 2022. PMID: 35466039 Free PMC article.

71

Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients.

Ramos KJ, Guimbellot JS, Valapour M, Bartlett LE, Wai TH, Goss CH, Pilewski JM, Faro A, Diamond JM; CFLTC Study Group. Ramos KJ, et al. Among authors: goss ch. J Cyst Fibros. 2022 Sep;21(5):745-752. doi: 10.1016/j.jcf.2022.04.009. Epub 2022 Apr 23. J Cyst Fibros. 2022. PMID: 35474016 Free PMC article.

72

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. Among authors: goss ch. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.

73

Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections.

Cogen JD, Nichols DP, Goss CH, Somayaji R. Cogen JD, et al. Among authors: goss ch. J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S32-S39. doi: 10.1093/jpids/piac061. J Pediatric Infect Dis Soc. 2022. PMID: 36069901 Free PMC article. Review.

74

Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.

Moshiree B, Freeman AJ, Vu PT, Khan U, Ufret-Vincenty C, Heltshe SL, Goss CH, Schwarzenberg SJ, Freedman SD, Borowitz D, Sathe M; GALAXY Study Group. Moshiree B, et al. Among authors: goss ch. J Cyst Fibros. 2023 Mar;22(2):266-274. doi: 10.1016/j.jcf.2022.10.006. Epub 2022 Oct 29. J Cyst Fibros. 2023. PMID: 36319569 Free PMC article.

75

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH; SIMPLIFY Study Group. Mayer-Hamblett N, et al. Among authors: goss ch. Lancet Respir Med. 2023 Apr;11(4):329-340. doi: 10.1016/S2213-2600(22)00434-9. Epub 2022 Nov 4. Lancet Respir Med. 2023. PMID: 36343646 Free PMC article. Clinical Trial.

76

Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020.

Cromwell EA, Ostrenga JS, Todd JV, Elbert A, Brown AW, Faro A, Goss CH, Marshall BC. Cromwell EA, et al. Among authors: goss ch. J Cyst Fibros. 2023 May;22(3):436-442. doi: 10.1016/j.jcf.2023.02.009. Epub 2023 Mar 13. J Cyst Fibros. 2023. PMID: 36922288 Free article.

77

Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis.

Jennerich AL, Downey L, Goss CH, Kapnadak SG, Pryor JB, Ramos KJ. Jennerich AL, et al. Among authors: goss ch. BMC Pulm Med. 2023 Mar 30;23(1):105. doi: 10.1186/s12890-023-02398-4. BMC Pulm Med. 2023. PMID: 36997883 Free PMC article.

78

Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis.

Somayaji R, Wessels ME, Milinic T, Ramos KJ, Mayer-Hamblett N, Ramsey BW, Heltshe S, Khan U, Goss CH. Somayaji R, et al. Among authors: goss ch. J Cyst Fibros. 2023 Jul;22(4):669-673. doi: 10.1016/j.jcf.2023.05.014. Epub 2023 Jun 5. J Cyst Fibros. 2023. PMID: 37286384

79

Role of hyperglycemia in cystic fibrosis pulmonary exacerbations.

Merjaneh L, Sidhaye AR, Vu PT, Heltshe SL, Goss CH, Flume PA, Kelly A, Rosenfeld M on behalf of the STOP2 investigators. Merjaneh L, et al. Among authors: goss ch. J Cyst Fibros. 2023 Sep;22(5):868-874. doi: 10.1016/j.jcf.2023.06.011. Epub 2023 Jun 30. J Cyst Fibros. 2023. PMID: 37394317

80

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.

McElvaney OJ, Heltshe SL, Odem-Davis K, West NE, Sanders DB, Fogarty B, VanDevanter DR, Flume PA, Goss CH; STOP2 Investigators. McElvaney OJ, et al. Among authors: goss ch. J Cyst Fibros. 2023 Sep;22(5):875-879. doi: 10.1016/j.jcf.2023.06.012. Epub 2023 Jul 6. J Cyst Fibros. 2023. PMID: 37407341

81

Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant.

Young D, Bartlett LE, Guimbellot J, Milinic T, Burdis N, Gill ER, Lease ED, Goss CH, Kapnadak SG, Ramos KJ. Young D, et al. Among authors: goss ch. J Cyst Fibros. 2023 Oct 3:S1569-1993(23)00921-9. doi: 10.1016/j.jcf.2023.09.017. Online ahead of print. J Cyst Fibros. 2023. PMID: 37798159

82

Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location.

Gold LS, Hansen RN, Heltshe SL, Flume PA, Goss CH, West NE, Sanders DB, Kessler L. Gold LS, et al. Among authors: goss ch. J Cyst Fibros. 2023 Oct 5:S1569-1993(23)00926-8. doi: 10.1016/j.jcf.2023.10.004. Online ahead of print. J Cyst Fibros. 2023. PMID: 37805355

83

Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.

Thornton CS, Caverly LJ, Kalikin LM, Carmody LA, McClellan S, LeBar W, Sanders DB, West NE, Goss CH, Flume PA, Heltshe SL, VanDevanter DR, LiPuma JJ. Thornton CS, et al. Among authors: goss ch. Ann Am Thorac Soc. 2024 Apr;21(4):595-603. doi: 10.1513/AnnalsATS.202306-576OC. Ann Am Thorac Soc. 2024. PMID: 37963297 Clinical Trial.

84

A longitudinal analysis of respiratory symptoms in people with cystic fibrosis with advanced lung disease on and off ETI.

Gill ER, Bartlett LE, Milinic T, Burdis N, Pilewski JM, Dunitz JM, Kapnadak SG, Goss CH, Ramos KJ. Gill ER, et al. Among authors: goss ch. J Cyst Fibros. 2024 Jan;23(1):161-164. doi: 10.1016/j.jcf.2023.11.008. Epub 2023 Nov 25. J Cyst Fibros. 2024. PMID: 38008684

85

Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.

McElvaney OJ, Heltshe SL, Odem-Davis K, West NE, Sanders DB, Fogarty B, VanDevanter DR, Flume PA, Goss CH. McElvaney OJ, et al. Among authors: goss ch. Ann Am Thorac Soc. 2023 Dec 14. doi: 10.1513/AnnalsATS.202308-673OC. Online ahead of print. Ann Am Thorac Soc. 2023. PMID: 38096105

86

The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial.

Gold LS, Hansen RN, Mayer-Hamblett N, Nichols DP, Gifford AH, Kloster M, Goss CH, Kessler L. Gold LS, et al. Among authors: goss ch. J Manag Care Spec Pharm. 2024 Jan;30(1):26-33. doi: 10.18553/jmcp.2024.30.1.26. J Manag Care Spec Pharm. 2024. PMID: 38153868 Free PMC article.

87

The effect of pregnancy on survival in women with cystic fibrosis.

Goss CH, Rubenfeld GD, Otto K, Aitken ML. Goss CH, et al. Chest. 2003 Oct;124(4):1460-8. doi: 10.1378/chest.124.4.1460. Chest. 2003. PMID: 14555580

88

Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis.

Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Goss CH, et al. Am J Respir Crit Care Med. 2004 Apr 1;169(7):816-21. doi: 10.1164/rccm.200306-779OC. Epub 2004 Jan 12. Am J Respir Crit Care Med. 2004. PMID: 14718248

89

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

Goss CH, Mayer-Hamblett N, Aitken ML, Rubenfeld GD, Ramsey BW. Goss CH, et al. Thorax. 2004 Nov;59(11):955-9. doi: 10.1136/thx.2003.017707. Thorax. 2004. PMID: 15516471 Free PMC article.

90

Clinical trial participants compared with nonparticipants in cystic fibrosis.

Goss CH, Rubenfeld GD, Ramsey BW, Aitken ML. Goss CH, et al. Am J Respir Crit Care Med. 2006 Jan 1;173(1):98-104. doi: 10.1164/rccm.200502-273OC. Epub 2005 Sep 28. Am J Respir Crit Care Med. 2006. PMID: 16192455 Free PMC article.

91

Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trials.

Sucharew H, Goss CH, Millard SP, Ramsey BW; Cystic Fibrosis Therapeutics Development Network. Sucharew H, et al. Among authors: goss ch. Contemp Clin Trials. 2006 Dec;27(6):561-70. doi: 10.1016/j.cct.2006.06.001. Epub 2006 Jun 9. Contemp Clin Trials. 2006. PMID: 16875884

92

Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.

Merlo CA, Boyle MP, Diener-West M, Marshall BC, Goss CH, Lechtzin N. Merlo CA, et al. Among authors: goss ch. Chest. 2007 Aug;132(2):562-8. doi: 10.1378/chest.06-2888. Epub 2007 Jul 23. Chest. 2007. PMID: 17646236

93

Patient-reported outcomes in cystic fibrosis.

Goss CH, Quittner AL. Goss CH, et al. Proc Am Thorac Soc. 2007 Aug 1;4(4):378-86. doi: 10.1513/pats.200703-039BR. Proc Am Thorac Soc. 2007. PMID: 17652505 Free PMC article. Review.

94

Risk factors for chronic kidney disease in adults with cystic fibrosis.

Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH. Quon BS, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1147-52. doi: 10.1164/rccm.201105-0932OC. Epub 2011 Jul 28. Am J Respir Crit Care Med. 2011. PMID: 21799076 Free PMC article.

95

A story of success: continuous quality improvement in cystic fibrosis care in the USA.

Quon BS, Goss CH. Quon BS, et al. Among authors: goss ch. Thorax. 2011 Dec;66(12):1106-8. doi: 10.1136/thoraxjnl-2011-200611. Epub 2011 Aug 3. Thorax. 2011. PMID: 21813618

96

Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis.

Quon BS, Mayer-Hamblett N, Aitken ML, Goss CH. Quon BS, et al. Among authors: goss ch. Chest. 2012 Jul;142(1):185-191. doi: 10.1378/chest.11-1926. Chest. 2012. PMID: 22222189 Free PMC article.

97

Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials.

Mayer-Hamblett N, Kloster M, Ramsey BW, Narkewicz MR, Saiman L, Goss CH. Mayer-Hamblett N, et al. Among authors: goss ch. Contemp Clin Trials. 2013 Mar;34(2):232-8. doi: 10.1016/j.cct.2012.11.005. Epub 2012 Nov 29. Contemp Clin Trials. 2013. PMID: 23200843 Free PMC article. Clinical Trial.

98

Country to country variation: what can be learnt from national cystic fibrosis registries.

Goss CH. Goss CH. Curr Opin Pulm Med. 2015 Nov;21(6):585-90. doi: 10.1097/MCP.0000000000000208. Curr Opin Pulm Med. 2015. PMID: 26390334 Review.

99

A 21-Year-Old Woman With Cystic Fibrosis, Abdominal Pain, and Recent Weight Loss.

Kapnadak SG, Goss CH, Aitken ML. Kapnadak SG, et al. Among authors: goss ch. Chest. 2015 Nov;148(5):e156-e160. doi: 10.1378/chest.15-1124. Chest. 2015. PMID: 26527444

100

Cystic Fibrosis is Associated with Adverse Neonatal Outcomes in Washington State, 1996-2013.

Ramos KJ, Sack CS, Mitchell KH, Goss CH, Starr JR. Ramos KJ, et al. Among authors: goss ch. J Pediatr. 2017 Jan;180:206-211.e1. doi: 10.1016/j.jpeds.2016.09.069. Epub 2016 Oct 25. J Pediatr. 2017. PMID: 27793338 Free PMC article.

101

Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time.

Crull MR, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, Goss CH. Crull MR, et al. Among authors: goss ch. BMC Pulm Med. 2016 Dec 7;16(1):176. doi: 10.1186/s12890-016-0333-y. BMC Pulm Med. 2016. PMID: 27927212 Free PMC article.

102

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS. Konstan MW, et al. Among authors: goss ch. Lancet Respir Med. 2017 Feb;5(2):107-118. doi: 10.1016/S2213-2600(16)30427-1. Epub 2016 Dec 21. Lancet Respir Med. 2017. PMID: 28011037 Clinical Trial.

103

Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).

Somayaji R, Ramos KJ, Kapnadak SG, Aitken ML, Goss CH. Somayaji R, et al. Among authors: goss ch. Presse Med. 2017 Jun;46(6 Pt 2):e109-e124. doi: 10.1016/j.lpm.2017.03.021. Epub 2017 May 26. Presse Med. 2017. PMID: 28554722 Review.

104

Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis.

Hurley MN, Fogarty A, McKeever TM, Goss CH, Rosenfeld M, Smyth AR. Hurley MN, et al. Among authors: goss ch. Ann Am Thorac Soc. 2018 Jan;15(1):42-48. doi: 10.1513/AnnalsATS.201705-376OC. Ann Am Thorac Soc. 2018. PMID: 29035090 Free PMC article.

105

Clinical characteristics of cystic fibrosis patients prior to lung transplantation: An international comparison between Canada and the United States.

Quon BS, Sykes J, Stanojevic S, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Faro A, Goss CH, Stephenson AL. Quon BS, et al. Among authors: goss ch. Clin Transplant. 2018 Mar;32(3):e13188. doi: 10.1111/ctr.13188. Epub 2018 Feb 11. Clin Transplant. 2018. PMID: 29292522 Free PMC article.

106

Changing Rates of Chronic Pseudomonas aeruginosa Infections in Cystic Fibrosis: A Population-Based Cohort Study.

Crull MR, Somayaji R, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, Nichols DP, Rowhani-Rahbar A, Goss CH. Crull MR, et al. Among authors: goss ch. Clin Infect Dis. 2018 Sep 14;67(7):1089-1095. doi: 10.1093/cid/ciy215. Clin Infect Dis. 2018. PMID: 29534149 Free PMC article.

107

Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

Goss CH, Kaneko Y, Khuu L, Anderson GD, Ravishankar S, Aitken ML, Lechtzin N, Zhou G, Czyz DM, McLean K, Olakanmi O, Shuman HA, Teresi M, Wilhelm E, Caldwell E, Salipante SJ, Hornick DB, Siehnel RJ, Becker L, Britigan BE, Singh PK. Goss CH, et al. Sci Transl Med. 2018 Sep 26;10(460):eaat7520. doi: 10.1126/scitranslmed.aat7520. Sci Transl Med. 2018. PMID: 30257953 Free PMC article. Clinical Trial.

108

Update in Cystic Fibrosis 2018.

Ramsey BW, Downey GP, Goss CH. Ramsey BW, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2019 May 15;199(10):1188-1194. doi: 10.1164/rccm.201902-0310UP. Am J Respir Crit Care Med. 2019. PMID: 30917288 Free PMC article. Review. No abstract available.

109

Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.

Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, Lease ED, Mulligan MS, Aitken ML, Gries CJ, Goss CH. Ramos KJ, et al. Among authors: goss ch. Chest. 2020 Apr;157(4):898-906. doi: 10.1016/j.chest.2019.11.043. Epub 2020 Jan 17. Chest. 2020. PMID: 31958441 Free PMC article.

110

Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.

Ramos KJ, Sykes J, Stanojevic S, Ma X, Ostrenga JS, Fink A, Quon BS, Marshall BC, Faro A, Petren K, Elbert A, Goss CH, Stephenson AL. Ramos KJ, et al. Among authors: goss ch. Chest. 2021 Sep;160(3):843-853. doi: 10.1016/j.chest.2021.04.010. Epub 2021 Apr 17. Chest. 2021. PMID: 33878343 Free PMC article.

111

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.

Thornton C, Somayaji R, Parkins M, Swain MG, Ramos KJ, Goss CH, Shaheen AA. Thornton C, et al. Among authors: goss ch. Am J Gastroenterol. 2021 Aug 1;116(8):1734-1737. doi: 10.14309/ajg.0000000000001275. Am J Gastroenterol. 2021. PMID: 33927124 Free PMC article.

112

COVID-19 vaccine prioritisation for people with cystic fibrosis.

Carr SB, Cosgriff R, Harutyunyan S, Middleton PG, Ruseckaite R, Ahern S, Daneau G, Filho LVRFDS, Stephenson AL, Cheng SY, Melo J, Corvol H, Burgel PR, Nährlich L, McKone E, Colombo C, Salvatore M, Padoan R, Abdrakhmanov O, Gulmans V, Byrnes CA, Amelina E, Kondratyeva E, Zhekayte E, Kashirskaya N, Zampoli M, Pastor-Vivero MD, Mondejar-Lopez P, de Monestrol I, Jung A, McClenaghan E, Brownlee K, Rizvi S, Goss CH, Elbert A, Faro A, Gutierrez H, Marshall BC. Carr SB, et al. Among authors: goss ch. J Cyst Fibros. 2021 Jul;20(4):715-716. doi: 10.1016/j.jcf.2021.03.028. Epub 2021 Apr 15. J Cyst Fibros. 2021. PMID: 33941502 Free PMC article. No abstract available.

113

Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study.

Goss CH, Fajac I, Jain R, Seibold W, Gupta A, Hsu MC, Sutharsan S, Davies JC, Mall MA. Goss CH, et al. Eur Respir J. 2022 Feb 17;59(2):2100746. doi: 10.1183/13993003.00746-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34385272 Free PMC article. Clinical Trial.

114

Body Mass Index Recovery after Lung Transplant for Cystic Fibrosis.

Pryor JB, Bradford MC, Jennerich AL, Wai TYH, Pilewski JM, Kapnadak SG, Aitken ML, Goss CH, Ramos KJ. Pryor JB, et al. Among authors: goss ch. Ann Am Thorac Soc. 2022 Jul;19(7):1130-1138. doi: 10.1513/AnnalsATS.202108-969OC. Ann Am Thorac Soc. 2022. PMID: 35044894 Free PMC article.

115

Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV₁ ≤ 50% Predicted.

Ramos KJ, Hee Wai T, Stephenson AL, Sykes J, Stanojevic S, Rodriguez PJ, Bansal A, Mayer-Hamblett N, Goss CH, Kapnadak SG. Ramos KJ, et al. Among authors: goss ch. Chest. 2022 Oct;162(4):757-767. doi: 10.1016/j.chest.2022.05.021. Epub 2022 May 26. Chest. 2022. PMID: 35643116 Free PMC article.

116

Contemporary cystic fibrosis incidence rates in Canada and the United States.

Stephenson AL, Swaleh S, Sykes J, Stanojevic S, Ma X, Quon BS, Faro A, Marshall B, Ramos KJ, Ostrenga J, Elbert A, Desai S, Cromwell E, Goss CH. Stephenson AL, et al. Among authors: goss ch. J Cyst Fibros. 2023 May;22(3):443-449. doi: 10.1016/j.jcf.2022.10.008. Epub 2022 Nov 10. J Cyst Fibros. 2023. PMID: 36371312

117

Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis.

Hart A, Cesar F, Zelnick LR, O'Connor N, Bailey Z, Lo J, Van Ness K, Stanaway IB, Bammler TK, MacDonald JW, Thau MR, Himmelfarb J, Goss CH, Aitken M, Kelly EJ, Bhatraju PK. Hart A, et al. Among authors: goss ch. J Cyst Fibros. 2023 Nov 8:S1569-1993(23)01671-5. doi: 10.1016/j.jcf.2023.10.021. Online ahead of print. J Cyst Fibros. 2023. PMID: 37949747

118

Olfactory loss in people with cystic fibrosis: Community perceptions and impact.

Miller JE, Liu CM, Zemanick ET, Woods JC, Goss CH, Taylor-Cousar JL, Beswick DM. Miller JE, et al. Among authors: goss ch. J Cyst Fibros. 2023 Nov 17:S1569-1993(23)01677-6. doi: 10.1016/j.jcf.2023.11.006. Online ahead of print. J Cyst Fibros. 2023. PMID: 37981480

119

Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries.

Calthorpe R, Rosenfeld M, Goss CH, Green N, Derleth M, Carr SB, Smyth A, Stewart I. Calthorpe R, et al. Among authors: goss ch. J Cyst Fibros. 2024 Feb 10:S1569-1993(24)00012-2. doi: 10.1016/j.jcf.2024.01.011. Online ahead of print. J Cyst Fibros. 2024. PMID: 38342635 Free article.

120

Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.

Hoppe JE, Sjoberg J, Hong G, Poch K, Zemanick ET, Thee S, Edmondson C, Patel D, Sathe M, Borowitz D, Putman MS, Lechtzin N, Riekert KA, Basile M, Goss CH, Jarosz ME, Rosenfeld M. Hoppe JE, et al. Among authors: goss ch. J Cyst Fibros. 2024 Feb 29:S1569-1993(24)00023-7. doi: 10.1016/j.jcf.2024.02.011. Online ahead of print. J Cyst Fibros. 2024. PMID: 38429150 Review.

121

Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.

Goss CH, Otto K, Aitken ML, Rubenfeld GD. Goss CH, et al. Am J Respir Crit Care Med. 2002 Aug 1;166(3):356-61. doi: 10.1164/rccm.2109078. Am J Respir Crit Care Med. 2002. PMID: 12153970

122

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Mayer-Hamblett N, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1550-5. doi: 10.1164/rccm.200202-087OC. Epub 2002 Aug 15. Am J Respir Crit Care Med. 2002. PMID: 12406843

123

Improved survival among young patients with cystic fibrosis.

Kulich M, Rosenfeld M, Goss CH, Wilmott R. Kulich M, et al. Among authors: goss ch. J Pediatr. 2003 Jun;142(6):631-6. doi: 10.1067/mpd.2003.197. J Pediatr. 2003. PMID: 12838190

124

Update on cystic fibrosis epidemiology.

Goss CH, Rosenfeld M. Goss CH, et al. Curr Opin Pulm Med. 2004 Nov;10(6):510-4. doi: 10.1097/01.mcp.0000138994.46519.72. Curr Opin Pulm Med. 2004. PMID: 15510059 Review.

125

Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.

Borowitz D, Goss CH, Stevens C, Hayes D, Newman L, O'Rourke A, Konstan MW, Wagener J, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann CM, Aitken ML, Mahl TC, Young KR Jr, Dunitz J, Murray FT. Borowitz D, et al. Among authors: goss ch. Pancreas. 2006 Apr;32(3):258-63. doi: 10.1097/01.mpa.0000202952.10612.21. Pancreas. 2006. PMID: 16628080 Clinical Trial.

126

CFTR genotype as a predictor of prognosis in cystic fibrosis.

McKone EF, Goss CH, Aitken ML. McKone EF, et al. Among authors: goss ch. Chest. 2006 Nov;130(5):1441-7. doi: 10.1378/chest.130.5.1441. Chest. 2006. PMID: 17099022

127

Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Goss CH, Burns JL. Goss CH, et al. Thorax. 2007 Apr;62(4):360-7. doi: 10.1136/thx.2006.060889. Thorax. 2007. PMID: 17387214 Free PMC article. Review.

128

Pulmonary function in the morbidly obese.

Saliman JA, Benditt JO, Flum DR, Oelschlager BK, Dellinger EP, Goss CH. Saliman JA, et al. Among authors: goss ch. Surg Obes Relat Dis. 2008 Sep-Oct;4(5):632-9; discussion 639. doi: 10.1016/j.soard.2008.06.010. Epub 2008 Jul 17. Surg Obes Relat Dis. 2008. PMID: 18722823 Free PMC article.

129

Influenza-associated cystic fibrosis pulmonary exacerbations.

Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Ortiz JR, et al. Among authors: goss ch. Chest. 2010 Apr;137(4):852-60. doi: 10.1378/chest.09-1374. Epub 2009 Dec 4. Chest. 2010. PMID: 19965953 Free PMC article.

130

Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007.

Ortiz JR, Neuzil KM, Victor JC, Aitken ML, Goss CH. Ortiz JR, et al. Among authors: goss ch. Chest. 2010 Dec;138(6):1448-55. doi: 10.1378/chest.10-0356. Epub 2010 May 21. Chest. 2010. PMID: 20495106 Free PMC article.

131

Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status.

Quon BS, Psoter K, Mayer-Hamblett N, Aitken ML, Li CI, Goss CH. Quon BS, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2012 Nov 15;186(10):1008-13. doi: 10.1164/rccm.201205-0949OC. Epub 2012 Sep 13. Am J Respir Crit Care Med. 2012. PMID: 22983958 Free PMC article.

132

Response.

Quon BS, Mayer-Hamblett N, Aitken ML, Goss CH. Quon BS, et al. Among authors: goss ch. Chest. 2013 Jan;143(1):272. doi: 10.1378/chest.12-2232. Chest. 2013. PMID: 23276859 Free PMC article. No abstract available.

133

Update in cystic fibrosis 2012.

Goss CH, Ratjen F. Goss CH, et al. Am J Respir Crit Care Med. 2013 May 1;187(9):915-9. doi: 10.1164/rccm.201301-0184UP. Am J Respir Crit Care Med. 2013. PMID: 23634859 Free PMC article. Review. No abstract available.

134

Management of comorbidities in older patients with cystic fibrosis.

Plant BJ, Goss CH, Plant WD, Bell SC. Plant BJ, et al. Among authors: goss ch. Lancet Respir Med. 2013 Apr;1(2):164-74. doi: 10.1016/S2213-2600(13)70025-0. Epub 2013 Mar 19. Lancet Respir Med. 2013. PMID: 24429097 Review.

135

Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.

Abdalla MY, Switzer BL, Goss CH, Aitken ML, Singh PK, Britigan BE. Abdalla MY, et al. Among authors: goss ch. Antimicrob Agents Chemother. 2015 Aug;59(8):4826-34. doi: 10.1128/AAC.00331-15. Epub 2015 Jun 1. Antimicrob Agents Chemother. 2015. PMID: 26033732 Free PMC article.

136

Remarkable long-term survival post-lung transplantation among Canadian patients with cystic fibrosis.

Ramos KJ, Goss CH. Ramos KJ, et al. Among authors: goss ch. J Heart Lung Transplant. 2015 Sep;34(9):1131-3. doi: 10.1016/j.healun.2015.05.010. Epub 2015 Jun 10. J Heart Lung Transplant. 2015. PMID: 26169665 No abstract available.

137

Tackling the increasing complexity of CF care.

Sawicki GS, Goss CH. Sawicki GS, et al. Among authors: goss ch. Pediatr Pulmonol. 2015 Oct;50 Suppl 40(0 40):S74-9. doi: 10.1002/ppul.23244. Pediatr Pulmonol. 2015. PMID: 26335957 Free PMC article. Review.

138

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett N, Zemanick ET, Hoover WC, VanDalfsen JM, Campbell P, Goss CH; STAR-too study team. Muhlebach MS, et al. Among authors: goss ch. Thorax. 2017 Apr;72(4):318-326. doi: 10.1136/thoraxjnl-2016-208949. Epub 2016 Nov 15. Thorax. 2017. PMID: 27852955 Free PMC article.

139

Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.

Ramos KJ, Somayaji R, Lease ED, Goss CH, Aitken ML. Ramos KJ, et al. Among authors: goss ch. BMC Pulm Med. 2017 Jan 19;17(1):21. doi: 10.1186/s12890-017-0367-9. BMC Pulm Med. 2017. PMID: 28103851 Free PMC article.

140

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Goss CH, Sykes J, Stanojevic S, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Quon BS, Stephenson AL. Goss CH, et al. Am J Respir Crit Care Med. 2018 Mar 15;197(6):768-775. doi: 10.1164/rccm.201707-1541OC. Am J Respir Crit Care Med. 2018. PMID: 29099606 Free PMC article.

141

Higher Plasma Endothelial Markers in Adults with Cystic Fibrosis Compared with Healthy Age-matched Control Subjects.

Bhatraju PK, Hisert KB, Aitken ML, Goss CH, Liles WC, Altemeier WA. Bhatraju PK, et al. Among authors: goss ch. Ann Am Thorac Soc. 2019 Jun;16(6):768-771. doi: 10.1513/AnnalsATS.201812-844RL. Ann Am Thorac Soc. 2019. PMID: 30889361 Free PMC article. No abstract available.

142

Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?

Parkins MD, Ramos KJ, Goss CH, Somayaji R. Parkins MD, et al. Among authors: goss ch. Eur Respir J. 2019 Apr 25;53(4):1801727. doi: 10.1183/13993003.01727-2018. Print 2019 Apr. Eur Respir J. 2019. PMID: 30956206 Free article. No abstract available.

143

Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis.

Jorth P, Ehsan Z, Rezayat A, Caldwell E, Pope C, Brewington JJ, Goss CH, Benscoter D, Clancy JP, Singh PK. Jorth P, et al. Among authors: goss ch. Cell Rep. 2019 Apr 23;27(4):1190-1204.e3. doi: 10.1016/j.celrep.2019.03.086. Cell Rep. 2019. PMID: 31018133 Free PMC article.

144

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. Bell SC, et al. Among authors: goss ch. Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Lancet Respir Med. 2020. PMID: 31570318 Free PMC article. Review.

145

Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States.

Stephenson AL, Ramos KJ, Sykes J, Ma X, Stanojevic S, Quon BS, Marshall BC, Petren K, Ostrenga JS, Fink AK, Faro A, Elbert A, Chaparro C, Goss CH. Stephenson AL, et al. Among authors: goss ch. J Heart Lung Transplant. 2021 Mar;40(3):201-209. doi: 10.1016/j.healun.2020.12.001. Epub 2020 Dec 7. J Heart Lung Transplant. 2021. PMID: 33386232 Free PMC article.

146

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.

Schlüter DK, Ostrenga JS, Carr SB, Fink AK, Faro A, Szczesniak RD, Keogh RH, Charman SC, Marshall BC, Goss CH, Taylor-Robinson D. Schlüter DK, et al. Among authors: goss ch. Thorax. 2022 Feb;77(2):136-142. doi: 10.1136/thoraxjnl-2021-216849. Epub 2021 May 11. Thorax. 2022. PMID: 33975926 Free PMC article.

147

Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation Community.

Kapnadak SG, Morrell ED, Wai TH, Goss CH, Shah PD, Merlo CA, Hachem RR, Ramos KJ. Kapnadak SG, et al. Among authors: goss ch. J Heart Lung Transplant. 2022 Jan;41(1):20-23. doi: 10.1016/j.healun.2021.10.008. Epub 2021 Oct 22. J Heart Lung Transplant. 2022. PMID: 34785136 Free PMC article.

148

Improving lung transplant outcomes in France: the high emergency lung transplantation programme.

Bayomy OF, Ramos KJ, Goss CH. Bayomy OF, et al. Among authors: goss ch. Eur Respir J. 2022 Jan 27;59(1):2102209. doi: 10.1183/13993003.02209-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 35086845 Free PMC article. No abstract available.

149

A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning-Based Risk Prediction Models.

Rodriguez PJ, Veenstra DL, Heagerty PJ, Goss CH, Ramos KJ, Bansal A. Rodriguez PJ, et al. Among authors: goss ch. Value Health. 2022 Mar;25(3):350-358. doi: 10.1016/j.jval.2021.11.1360. Epub 2021 Dec 22. Value Health. 2022. PMID: 35227445 Free PMC article.

150

Diagnosis and Management of Cystic Fibrosis Exacerbations.

Milinic T, McElvaney OJ, Goss CH. Milinic T, et al. Among authors: goss ch. Semin Respir Crit Care Med. 2023 Apr;44(2):225-241. doi: 10.1055/s-0042-1760250. Epub 2023 Feb 6. Semin Respir Crit Care Med. 2023. PMID: 36746183 Free PMC article. Review.

151

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.

Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW. Goss CH, et al. Adv Drug Deliv Rev. 2002 Dec 5;54(11):1505-28. doi: 10.1016/s0169-409x(02)00163-1. Adv Drug Deliv Rev. 2002. PMID: 12458158 Review.

152

Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.

Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F; AZ0004 Macrolide Study Team. Saiman L, et al. Among authors: goss ch. Pediatr Pulmonol. 2012 Jul;47(7):641-8. doi: 10.1002/ppul.21601. Epub 2012 Jan 3. Pediatr Pulmonol. 2012. PMID: 22684984 Clinical Trial.

153

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection.

Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, Young KR, Saiman L, Burns JL, Govan JR, Ramsey B, Gupta R; Arikace Study Group. Clancy JP, et al. Among authors: goss ch. Thorax. 2013 Sep;68(9):818-25. doi: 10.1136/thoraxjnl-2012-202230. Epub 2013 Jun 8. Thorax. 2013. PMID: 23749840 Free PMC article. Clinical Trial.

154

Children and young adults with CF in the USA have better lung function compared with the UK.

Goss CH, MacNeill SJ, Quinton HB, Marshall BC, Elbert A, Knapp EA, Petren K, Gunn E, Osmond J, Bilton D. Goss CH, et al. Thorax. 2015 Mar;70(3):229-36. doi: 10.1136/thoraxjnl-2014-205718. Epub 2014 Sep 25. Thorax. 2015. PMID: 25256255 Free PMC article.

155

Prevalence of symptoms of depression and anxiety in adults with cystic fibrosis based on the PHQ-9 and GAD-7 screening questionnaires.

Quon BS, Bentham WD, Unutzer J, Chan YF, Goss CH, Aitken ML. Quon BS, et al. Among authors: goss ch. Psychosomatics. 2015 Jul-Aug;56(4):345-53. doi: 10.1016/j.psym.2014.05.017. Epub 2014 Jun 2. Psychosomatics. 2015. PMID: 25556569

156

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Stephenson AL, Sykes J, Stanojevic S, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink AK, Elbert A, Goss CH. Stephenson AL, et al. Among authors: goss ch. Ann Intern Med. 2017 Apr 18;166(8):537-546. doi: 10.7326/M16-0858. Epub 2017 Mar 14. Ann Intern Med. 2017. PMID: 28288488 Free PMC article.

157

Palliative Care Needs of Individuals with Cystic Fibrosis: Perspectives of Multiple Stakeholders.

Dellon EP, Basile M, Hobler MR, Georgiopoulos AM, Chen E, Goggin J, Goss CH, Hempstead SE, Faro A, Kavalieratos D. Dellon EP, et al. Among authors: goss ch. J Palliat Med. 2020 Jul;23(7):957-963. doi: 10.1089/jpm.2019.0464. Epub 2020 Feb 5. J Palliat Med. 2020. PMID: 32023421 Free PMC article.

158

Palliative care skills in CF: Perspectives of adults with CF, caregivers, and CF care team members.

Trandel ET, Kavalieratos D, Basile M, Hobler MR, Georgiopoulos AM, Chen E, Goggin JL, Goss CH, Hempstead SE, Faro A, Dellon EP. Trandel ET, et al. Among authors: goss ch. Pediatr Pulmonol. 2020 Aug;55(8):2017-2024. doi: 10.1002/ppul.24806. Epub 2020 May 8. Pediatr Pulmonol. 2020. PMID: 32384215 Free PMC article.

159

Assessing Practices, Beliefs, and Attitudes about Palliative Care among People with Cystic Fibrosis, Their Caregivers, and Clinicians: Results of a Content Analysis.

Basile M, Jojan L, Hobler MR, Dellon EP, Georgiopoulos AM, Goggin JL, Chen E, Goss CH, Hempstead SE, Faro A, Kavalieratos D. Basile M, et al. Among authors: goss ch. J Palliat Med. 2021 Nov;24(11):1650-1656. doi: 10.1089/jpm.2020.0725. Epub 2021 Apr 20. J Palliat Med. 2021. PMID: 33885355 Free PMC article.

160

Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis.

Aitken ML, Greene KE, Tonelli MR, Burns JL, Emerson JC, Goss CH, Gibson RL. Aitken ML, et al. Among authors: goss ch. Chest. 2003 Mar;123(3):792-9. doi: 10.1378/chest.123.3.792. Chest. 2003. PMID: 12628880

161

Out-of-hospital fluid in severe sepsis: effect on early resuscitation in the emergency department.

Seymour CW, Cooke CR, Mikkelsen ME, Hylton J, Rea TD, Goss CH, Gaieski DF, Band RA. Seymour CW, et al. Among authors: goss ch. Prehosp Emerg Care. 2010 Apr-Jun;14(2):145-52. doi: 10.3109/10903120903524997. Prehosp Emerg Care. 2010. PMID: 20199228 Free PMC article.

162

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F; AZ0004 Azithromycin Study Group. Saiman L, et al. Among authors: goss ch. JAMA. 2010 May 5;303(17):1707-15. doi: 10.1001/jama.2010.563. JAMA. 2010. PMID: 20442386 Clinical Trial.

163

Obese patients with idiopathic pulmonary fibrosis have a higher 90-day mortality risk with bilateral lung transplantation.

Gries CJ, Bhadriraju S, Edelman JD, Goss CH, Raghu G, Mulligan MS. Gries CJ, et al. Among authors: goss ch. J Heart Lung Transplant. 2015 Feb;34(2):241-6. doi: 10.1016/j.healun.2014.09.031. Epub 2014 Sep 28. J Heart Lung Transplant. 2015. PMID: 25447567

164

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, Elbert A, Petren KM, Marshall BC. Knapp EA, et al. Among authors: goss ch. Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC. Ann Am Thorac Soc. 2016. PMID: 27078236

165

Cystic fibrosis.

Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Ratjen F, et al. Among authors: goss ch. Nat Rev Dis Primers. 2015 May 14;1:15010. doi: 10.1038/nrdp.2015.10. Nat Rev Dis Primers. 2015. PMID: 27189798 Free PMC article. Review.

166

Data that empower: The success and promise of CF patient registries.

Fink AK, Loeffler DR, Marshall BC, Goss CH, Morgan WJ. Fink AK, et al. Among authors: goss ch. Pediatr Pulmonol. 2017 Nov;52(S48):S44-S51. doi: 10.1002/ppul.23790. Epub 2017 Sep 14. Pediatr Pulmonol. 2017. PMID: 28910520 Review.

167

Associations between demographic characteristics and unmet supportive care needs in adults with cystic fibrosis.

Obregon LL, Jeong K, Hoydich ZP, Yabes J, Pilewski J, Richless C, Moreines LT, Dellon EP, Goss CH, Arnold RM, Kavalieratos D. Obregon LL, et al. Among authors: goss ch. BMJ Support Palliat Care. 2022 Jul;12(e2):e281-e284. doi: 10.1136/bmjspcare-2019-001819. Epub 2019 Aug 31. BMJ Support Palliat Care. 2022. PMID: 31473650 Free PMC article.

168

Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.

Durfey SL, Pipavath S, Li A, Vo AT, Ratjen A, Carter S, Morgan SJ, Radey MC, Grogan B, Salipante SJ, Welsh MJ, Stoltz DA, Goss CH, McKone EF, Singh PK. Durfey SL, et al. Among authors: goss ch. mBio. 2021 Dec 21;12(6):e0314821. doi: 10.1128/mbio.03148-21. Epub 2021 Dec 14. mBio. 2021. PMID: 34903059 Free PMC article. Clinical Trial.

169

The lung allocation score and other available models lack predictive accuracy for post-lung transplant survival.

Brahmbhatt JM, Hee Wai T, Goss CH, Lease ED, Merlo CA, Kapnadak SG, Ramos KJ. Brahmbhatt JM, et al. Among authors: goss ch. J Heart Lung Transplant. 2022 Aug;41(8):1063-1074. doi: 10.1016/j.healun.2022.05.008. Epub 2022 May 20. J Heart Lung Transplant. 2022. PMID: 35690561 Free PMC article.

170

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.

Sawicki GS, Konstan MW, McKone EF, Moss RB, Lubarsky B, Suthoff E, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan WJ, Duncan ME, Yang Y. Sawicki GS, et al. Among authors: goss ch. Pulm Ther. 2022 Dec;8(4):385-395. doi: 10.1007/s41030-022-00202-y. Epub 2022 Nov 1. Pulm Ther. 2022. PMID: 36319933 Free PMC article.

171

Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.

Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, Mulligan MS. Naidu BV, et al. Among authors: goss ch. J Thorac Cardiovasc Surg. 2004 May;127(5):1502-8. doi: 10.1016/j.jtcvs.2003.08.019. J Thorac Cardiovasc Surg. 2004. PMID: 15116014 Free article.

172

Disease-specific reference equations for lung function in patients with cystic fibrosis.

Kulich M, Rosenfeld M, Campbell J, Kronmal R, Gibson RL, Goss CH, Ramsey B. Kulich M, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2005 Oct 1;172(7):885-91. doi: 10.1164/rccm.200410-1335OC. Epub 2005 Jun 23. Am J Respir Crit Care Med. 2005. PMID: 15976373

173

Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation.

McCourtie AS, Merry HE, Farivar AS, Goss CH, Mulligan MS. McCourtie AS, et al. Among authors: goss ch. Ann Thorac Surg. 2008 Mar;85(3):1056-60. doi: 10.1016/j.athoracsur.2007.10.058. Ann Thorac Surg. 2008. PMID: 18291196

174

Maternal stress: a cause of childhood asthma?

Quon BS, Goss CH. Quon BS, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2012 Jul 15;186(2):116-7. doi: 10.1164/rccm.201205-0871ED. Am J Respir Crit Care Med. 2012. PMID: 22798410 No abstract available.

175

Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009.

Ortiz JR, Neuzil KM, Rue TC, Zhou H, Shay DK, Cheng PY, Cooke CR, Goss CH. Ortiz JR, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2013 Sep 15;188(6):710-5. doi: 10.1164/rccm.201212-2341OC. Am J Respir Crit Care Med. 2013. PMID: 23855650

176

Highly effective cystic fibrosis clinical research teams: critical success factors.

Retsch-Bogart GZ, Van Dalfsen JM, Marshall BC, George C, Pilewski JM, Nelson EC, Goss CH, Ramsey BW. Retsch-Bogart GZ, et al. Among authors: goss ch. J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S714-23. doi: 10.1007/s11606-014-2896-8. J Gen Intern Med. 2014. PMID: 25029977 Free PMC article.

177

The burden of influenza-associated critical illness hospitalizations.

Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR. Ortiz JR, et al. Among authors: goss ch. Crit Care Med. 2014 Nov;42(11):2325-32. doi: 10.1097/CCM.0000000000000545. Crit Care Med. 2014. PMID: 25148596 Free PMC article.

178

Adult-onset asthma prevention. Should we be investing in antioxidant defense?

Quon BS, Goss CH. Quon BS, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2015 Jan 1;191(1):4-5. doi: 10.1164/rccm.201411-2089ED. Am J Respir Crit Care Med. 2015. PMID: 25551340 Free PMC article. No abstract available.

179

Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011.

Goss LB, Ortiz JR, Okamura DM, Hayward K, Goss CH. Goss LB, et al. Among authors: goss ch. PLoS One. 2015 Jun 18;10(6):e0128920. doi: 10.1371/journal.pone.0128920. eCollection 2015. PLoS One. 2015. PMID: 26087254 Free PMC article.

180

American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report.

Bender BG, Krishnan JA, Chambers DA, Cloutier MM, Riekert KA, Rand CS, Schatz M, Thomson CC, Wilson SR, Apter A, Carson SS, George M, Gerald JK, Gerald L, Goss CH, Okelo SO, Mularski RA, Nguyen HQ, Patel MR, Szefler SJ, Weiss CH, Wilson KC, Freemer M. Bender BG, et al. Among authors: goss ch. Ann Am Thorac Soc. 2015 Dec;12(12):S213-21. doi: 10.1513/AnnalsATS.201506-367OT. Ann Am Thorac Soc. 2015. PMID: 26653201 Free PMC article. Review.

181

Exploring Opportunities for Primary Outpatient Palliative Care for Adults with Cystic Fibrosis: A Mixed-Methods Study of Patients' Needs.

Hobler MR, Engelberg RA, Curtis JR, Ramos KJ, Zander MI, Howard SS, Goss CH, Aitken ML. Hobler MR, et al. Among authors: goss ch. J Palliat Med. 2018 Apr;21(4):513-521. doi: 10.1089/jpm.2017.0259. Epub 2018 Jan 3. J Palliat Med. 2018. PMID: 29298400 Free PMC article.

182

An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM 1.

Goss CH, Jain R, Seibold W, Picard AC, Hsu MC, Gupta A, Fajac I. Goss CH, et al. ERJ Open Res. 2020 Dec 7;6(4):00395-2020. doi: 10.1183/23120541.00395-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33313307 Free PMC article.

183

Lung Allocation Score Exceptions in Persons with Cystic Fibrosis Undergoing Lung Transplant.

Bayomy OF, Bradford MC, Milinic T, Kapnadak SG, Morrell ED, Lease ED, Goss CH, Ramos KJ. Bayomy OF, et al. Among authors: goss ch. Ann Am Thorac Soc. 2024 Feb;21(2):271-278. doi: 10.1513/AnnalsATS.202306-509OC. Ann Am Thorac Soc. 2024. PMID: 37878995

184

Incidence of acute lung injury in the United States.

Goss CH, Brower RG, Hudson LD, Rubenfeld GD; ARDS Network. Goss CH, et al. Crit Care Med. 2003 Jun;31(6):1607-11. doi: 10.1097/01.CCM.0000063475.65751.1D. Crit Care Med. 2003. PMID: 12794394

185

Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.

Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK. Goss CH, et al. Chest. 2003 Dec;124(6):2148-55. doi: 10.1378/chest.124.6.2148. Chest. 2003. PMID: 14665494

186

Clinician statements and family satisfaction with family conferences in the intensive care unit.

Stapleton RD, Engelberg RA, Wenrich MD, Goss CH, Curtis JR. Stapleton RD, et al. Among authors: goss ch. Crit Care Med. 2006 Jun;34(6):1679-85. doi: 10.1097/01.CCM.0000218409.58256.AA. Crit Care Med. 2006. PMID: 16625131

187

Hospital volume and the outcomes of mechanical ventilation.

Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O'Brien CR, Rubenfeld GD. Kahn JM, et al. Among authors: goss ch. N Engl J Med. 2006 Jul 6;355(1):41-50. doi: 10.1056/NEJMsa053993. N Engl J Med. 2006. PMID: 16822995 Free article.

188

Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.

Borowitz D, Goss CH, Limauro S, Konstan MW, Blake K, Casey S, Quittner AL, Murray FT. Borowitz D, et al. Among authors: goss ch. J Pediatr. 2006 Nov;149(5):658-662. doi: 10.1016/j.jpeds.2006.07.030. J Pediatr. 2006. PMID: 17095338 Clinical Trial.

189

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

Gerbino AJ, Goss CH, Molitor JA. Gerbino AJ, et al. Among authors: goss ch. Chest. 2008 Feb;133(2):455-60. doi: 10.1378/chest.06-2861. Epub 2007 Dec 10. Chest. 2008. PMID: 18071023

190

Should we stop using intravenous gentamicin in patients with cystic fibrosis?

Goss CH. Goss CH. Thorax. 2008 Jun;63(6):479-80. doi: 10.1136/thx.2007.094821. Thorax. 2008. PMID: 18511632 No abstract available.

191

Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery.

Snyder ML, Goss CH, Neradilek B, Polissar NL, Mosenifar Z, Wise RA, Fishman AP, Benditt JO; National Emphysema Treatment Trial Research Group. Snyder ML, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2008 Aug 15;178(4):339-45. doi: 10.1164/rccm.200712-1826OC. Epub 2008 Jun 5. Am J Respir Crit Care Med. 2008. PMID: 18535254 Free PMC article. Clinical Trial.

192

Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia.

Cecere LM, Rubenfeld GD, Park DR, Root RK, Goss CH. Cecere LM, et al. Among authors: goss ch. Respiration. 2010;79(2):128-36. doi: 10.1159/000255764. Epub 2009 Nov 4. Respiration. 2010. PMID: 19887771 Free PMC article.

193

Genetic variation in the FAS gene and associations with acute lung injury.

Glavan BJ, Holden TD, Goss CH, Black RA, Neff MJ, Nathens AB, Martin TR, Wurfel MM; ARDSnet Investigators. Glavan BJ, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2011 Feb 1;183(3):356-63. doi: 10.1164/rccm.201003-0351OC. Epub 2010 Sep 2. Am J Respir Crit Care Med. 2011. PMID: 20813889 Free PMC article.

194

Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center.

Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, Cangelosi GA, Dirac MA, Olivier KN, Brown-Elliott BA, McNulty S, Wallace RJ Jr. Aitken ML, et al. Among authors: goss ch. Am J Respir Crit Care Med. 2012 Jan 15;185(2):231-2. doi: 10.1164/ajrccm.185.2.231. Am J Respir Crit Care Med. 2012. PMID: 22246710 No abstract available.

195

Nature and correlates of post-traumatic stress symptomatology in lung transplant recipients.

Gries CJ, Dew MA, Curtis JR, Edelman JD, DeVito Dabbs A, Pilewski JM, Goss CH, Mulligan MS, White DB. Gries CJ, et al. Among authors: goss ch. J Heart Lung Transplant. 2013 May;32(5):525-32. doi: 10.1016/j.healun.2013.01.1046. J Heart Lung Transplant. 2013. PMID: 23570741 Free PMC article.

196

Hypoglycemia in adults with cystic fibrosis during oral glucose tolerance testing.

Hirsch IB, Janci MM, Goss CH, Aitken ML. Hirsch IB, et al. Among authors: goss ch. Diabetes Care. 2013 Aug;36(8):e121-2. doi: 10.2337/dc12-1859. Diabetes Care. 2013. PMID: 23881975 Free PMC article. No abstract available.

197

The yin and yang of indoor airborne exposures to endotoxin.

Goss CH, Mayer-Hamblett N. Goss CH, et al. Am J Respir Crit Care Med. 2013 Nov 15;188(10):1181-3. doi: 10.1164/rccm.201309-1703ED. Am J Respir Crit Care Med. 2013. PMID: 24236583 Free PMC article. No abstract available.

198

The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.

Schechter MS, Fink AK, Homa K, Goss CH. Schechter MS, et al. Among authors: goss ch. BMJ Qual Saf. 2014 Apr;23 Suppl 1:i9-14. doi: 10.1136/bmjqs-2013-002378. Epub 2014 Jan 17. BMJ Qual Saf. 2014. PMID: 24443584 Review. No abstract available.

199

Unintended consequences of therapy in the intensive care unit.

Kim R, Goss CH. Kim R, et al. Among authors: goss ch. JAMA Intern Med. 2014 Apr;174(4):574-6. doi: 10.1001/jamainternmed.2013.13509. JAMA Intern Med. 2014. PMID: 24534847 No abstract available.

200

Inhaled antibiotics for lower airway infections.

Quon BS, Goss CH, Ramsey BW. Quon BS, et al. Among authors: goss ch. Ann Am Thorac Soc. 2014 Mar;11(3):425-34. doi: 10.1513/AnnalsATS.201311-395FR. Ann Am Thorac Soc. 2014. PMID: 24673698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page